AACE 2026: Tirzepatide Leads HbA1C Reduction, Semaglutide Leads Weight Loss Tags hBA1c GLP-1 agonists Read more about AACE 2026: Tirzepatide Leads HbA1C Reduction, Semaglutide Leads Weight Loss
SGLT2 Inhibitors Linked to Lower Rejection Post Heart Transplantation Tags hBA1c SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Linked to Lower Rejection Post Heart Transplantation
Weekly Efsitora Achieves HbA1c <7% With Low Hypoglycemia Tags Hypoglycemia Long acting Read more about Weekly Efsitora Achieves HbA1c
Sitagliptin-Based Triple FDC Lowers HbA1c in Uncontrolled T2DM Tags hBA1c Sulphonylureas DPP-4 inhibitors Biguanide Read more about Sitagliptin-Based Triple FDC Lowers HbA1c in Uncontrolled T2DM
Lp(a) Linked to Lower T2DM Risk Only at Higher HbA1c Levels Tags Coronary artery disease Heart disease hBA1c Read more about Lp(a) Linked to Lower T2DM Risk Only at Higher HbA1c Levels
AHCL Systems Achieved Similar TITR Above 50% in T1DM Tags hBA1c Insulin Pumps Continuous glucose monitoring (CGM) Read more about AHCL Systems Achieved Similar TITR Above 50% in T1DM
CGM Detected Dialysis-Cycle Glucose Patterns Beyond HbA1c Tags hBA1c Continuous glucose monitoring (CGM) Read more about CGM Detected Dialysis-Cycle Glucose Patterns Beyond HbA1c
Anagliptin Improved HbA1c Added to Metformin and Empagliflozin Tags hBA1c DPP-4 inhibitors Biguanide SGLT-2 Inhibitor Read more about Anagliptin Improved HbA1c Added to Metformin and Empagliflozin
Finerenone Benefit Persisted Across Baseline Diabetes Care Goals Tags Lipoprotein(a) hBA1c GLP-1 agonists SGLT-2 Inhibitor Read more about Finerenone Benefit Persisted Across Baseline Diabetes Care Goals
1-Hour Glucose Challenge Test May Streamline CFRD Screening Tags Cystic Fibrosis–Related Diabetes (CFRD) hBA1c Read more about 1-Hour Glucose Challenge Test May Streamline CFRD Screening